This trial is active, not recruiting.

Condition ewing's sarcoma
Treatment vincristine, actinomycin-d, ifosfamide
Sponsor King Faisal Specialist Hospital & Research Center
Start date June 2003
End date June 2013
Trial size 10 participants
Trial identifier NCT00541411, RAC#2031-065


Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide combination chemotherapy in Ewing's Sarcoma

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose treatment

Primary Outcomes

time frame: overall

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Patients with Ewing's Sarcoma

Additional Information

Principal investigator Muhammad Memon, MD
Trial information was received from ClinicalTrials.gov and was last updated in April 2012.
Information provided to ClinicalTrials.gov by King Faisal Specialist Hospital & Research Center.